Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06559475 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Multicenter, Randomized Controlled Clinical Investigation to Evaluate the Safety and Effectiveness of the Super-Bore 8/7F Aspiration Catheters in the Treatment of Acute Intracranial Large Vessel Occlusion

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 18, 2024 (before its estimated December 1, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Start date: Sep 1, 2024 to Dec 16, 2024v2 Show 6 more changesShow less
    • Primary completion date: Sep 1, 2025 to Dec 1, 2025
    • Study completion date: Dec 1, 2025 to Apr 1, 2026
    • Interventions: Conventional thrombectomy device treatment group (Procedure), Super-Bore 8F Thrombosis Aspiration Catheter treatment group (Procedure) to Conventional thrombectomy device treatment group (Procedure), Super-Bore Thrombosis Aspiration Catheter treatment group (Procedure)
    • Eligibility criteria expanded, about 158 words
    • Secondary endpoints revised (2)
    • Study title revised
  2. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To Evaluate the Safety and Efficacy of the Super-Bore 8/7F Thrombosis Aspiration Catheter in the Treatment of Acute Intracranial Large Vessel Occlusion.
Trial Details
NCT Number NCT06559475
Lead Sponsor The First Affiliated Hospital of University of Science and Technology of China
Conditions
(from sponsor)
Acute Ischemic Stroke, Endovascular Thrombectomy
Related terms Ischemic Stroke
Enrollment 360 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov